Hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with essential hypertension in the national basic public health service system: or self-reported history of hypertension; or are taking any antihypertensive drugs; or measured blood pressure thrice >140/90mmHg; 2. Meals at home at least 5 days a week; 3. >=18 years old and <=75 years old; 4. Can communicate normally with researchers; 5. Provide informed consent.
Exclusion criteria
Exclusion criteria: 1. Participants or family members living with them report having severe kidney diseases (including: Polycystic Kidney Disease with autosomal dominant or autosomal recessive inheritance, a history of kidney transplantation, acute kidney injury, Chronic Kidney Disease (CKD) in stage G3b or G4 or G5, systemic lupus erythematosus nephritis or hyperkalemia, or a history of hyperkalemia. Definition of hyperkalemia: Serum potassium > 5.5 mmol/L, and pseudo-hyperkalemia is excluded; 2. The participant or any family member living with them is taking any potassium-sparing diuretic or potassium-supplementing drug; 3. Currently consuming low-sodium salt or participating in other dietary intervention programs; 4. Currently suffering from a serious and major illness; 5. One family member living together has participated in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of people who purchased potassium-enriched salt substitute at least once in three months; | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of people who used potassium-enriched salt substitute at least once in the three months following randomization;Systolic pressure;Diastolic pressure;Estimated 24-hour urinary sodium excretion;Estimated 24-hour urinary potassium excretion;KAP towards salt reduction; | — |
Countries
China
Contacts
School of Public Health, Harbin Medical University